Literature DB >> 11272890

A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.

A Sakamoto1, Y Oda, Y Iwamoto, M Tsuneyoshi.   

Abstract

Fibrous dysplasia and osteofibrous dysplasia are both benign fibro-osseous lesions of the bone and are generally seen during childhood or adolescence. Histologically, the features of these bone lesions sometimes look quite similar, but their precise nature remains controversial. Mutation of the alpha subunit of signal-transducing G proteins (Gsalpha), with an increase in cyclic adenosine monophosphate (cAMP) formation, has been implicated in the development of multiple endocrinopathies of the Albright-McCune syndrome and in the development of fibrous dysplasia. We studied Gsalpha mutation at the Arg201. codon in seven cases of fibrous dysplasia (six monostotic lesions and one polyostotic lesion) and seven cases of osteofibrous dysplasia using formalin-fixed, paraffin-embedded tissue, by means of polymerase chain reaction-restriction fragment length polymorphism and direct sequencing analysis. All of the seven cases of fibrous dysplasia showed missense point mutations in Gsalpha at the Arg201 codon that resulted in Arg-to-His substitution in three cases and Arg-to-Cys substitution in four cases. On the other hand, the seven cases of osteofibrous dysplasia and the normal bone used as a control showed no such mutation. These data suggest that fibrous dysplasia and osteofibrous dysplasia have different pathogeneses and that the detection of Gsalpha mutation at the Arg201 codon is quite useful for distinguishing between these lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11272890      PMCID: PMC1906902          DOI: 10.1016/s1525-1578(10)60618-6

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  25 in total

1.  A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours.

Authors:  E Clementi; N Malgaretti; J Meldolesi; R Taramelli
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

2.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

3.  Adamantinoma of long bones. A clinicopathologic study of 85 cases.

Authors:  G L Keeney; K K Unni; J W Beabout; D J Pritchard
Journal:  Cancer       Date:  1989-08-01       Impact factor: 6.860

Review 4.  The McCune-Albright syndrome.

Authors:  M Danon; J D Crawford
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1987

5.  A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expressions of c-fos and c-jun products and bone matrix proteins: a clinicopathologic review and immunohistochemical study of c-fos, c-jun, type I collagen, osteonectin, osteopontin, and osteocalcin.

Authors:  A Sakamoto; Y Oda; Y Iwamoto; M Tsuneyoshi
Journal:  Hum Pathol       Date:  1999-12       Impact factor: 3.466

Review 6.  GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.

Authors:  L Vallar
Journal:  Biochem Soc Symp       Date:  1990

7.  Osteofibrous dysplasia of long bones a new clinical entity.

Authors:  M Campanacci
Journal:  Ital J Orthop Traumatol       Date:  1976-08

8.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

9.  Ossifying fibroma of long bone: its distinction from fibrous dysplasia and its association with adamantinoma of long bone.

Authors:  S F Markel
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493

10.  Osteofibrous dysplasia (ossifying fibroma) of the tibia and fibula and adamantinoma. A case report.

Authors:  A Alguacil-Garcia; A Alonso; N M Pettigrew
Journal:  Am J Clin Pathol       Date:  1984-10       Impact factor: 2.493

View more
  10 in total

Review 1.  [Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects].

Authors:  Sigrun Egner-Höbarth; H Welkerling; R Windhager
Journal:  Orthopade       Date:  2007-02       Impact factor: 1.087

Review 2.  Sclerotic bone lesions caused by non-infectious and non-neoplastic diseases: a review of the imaging and clinicopathologic findings.

Authors:  Vaibhav Gulati; Majid Chalian; Jaehyuck Yi; Uma Thakur; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2020-10-11       Impact factor: 2.199

3.  Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions.

Authors:  Qi Liang; Minqi Wei; LeAnn Hodge; Julie C Fanburg-Smith; Ann Nelson; Markku Miettinen; Robert D Foss; Guanghua Wang
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

Review 4.  Benign fibro-osseous lesions of the craniofacial complex. A review.

Authors:  Roy Eversole; Lan Su; Samir ElMofty
Journal:  Head Neck Pathol       Date:  2008-05-13

5.  GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues.

Authors:  George Jour; Alifya Oultache; Justyna Sadowska; Talia Mitchell; John Healey; Khedoudja Nafa; Meera Hameed
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-10

6.  Management of congenital pseudarthrosis of the tibia with the Ilizarov method in a paediatric population: influence of aetiological factors.

Authors:  Dmitry Y Borzunov; Alexander Y Chevardin; Alexander I Mitrofanov
Journal:  Int Orthop       Date:  2015-11-07       Impact factor: 3.075

7.  Autosomal dominant mesomandibular fibro-osseous dysplasia: a self-resolving inherited fibro-osseous lesion of the jaws.

Authors:  Ioannis G Koutlas; Cynthia L Forsman; Stephanos Kyrkanides; William S Oetting; Anna Petryk
Journal:  Front Physiol       Date:  2012-12-06       Impact factor: 4.566

8.  Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.

Authors:  Su-Jin Shin; Seok Joo Lee; Sang Kyum Kim
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

Review 9.  The nature of fibrous dysplasia.

Authors:  Liviu Feller; Neil H Wood; Razia A G Khammissa; Johan Lemmer; Erich J Raubenheimer
Journal:  Head Face Med       Date:  2009-11-09       Impact factor: 2.151

10.  Osteofibrous Dysplasia managed with Extraperiosteal excision, Autologous free fibular graft and bone graft substitute.

Authors:  Vineet T Abraham; Chandrasekaran Marimuthu; Ravichandran Subbaraj; Nandakumar Rengarajan
Journal:  J Orthop Case Rep       Date:  2015 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.